Neola Medical ABOSTO:NEOLA +3.93%29 FCF Yield % is -15.55 as of Jul. 07, 2026. GuruFocus rates OSTO:NEOLA with a GF Score™ of 29/100. The stock has 1 warning sign investors should review. Among 856 Medical Devices & Instruments companies, Neola Medical AB ranks worse than 79.67% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Neola Medical AB's FCF Yield % or its related term are showing as below:
OSTO:NEOLA'
s FCF Yield % Range Over the Past 10 Years
Min: -70.05 Med: -17.99 Max: -9.9
Current: -15.55
During the past 8 years, the highest FCF Yield % of Neola Medical AB was -9.90%. The lowest was -70.05%. And the median was -17.99%.
OSTO:NEOLA's FCF Yield % is ranked worse than 79.67% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: -0.39
vs OSTO:NEOLA: -15.55
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Neola Medical AB FCF Yield % Related Terms
Neola Medical AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Neola Medical AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:NEOLA vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Neola Medical AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neola Medical AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Neola Medical AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neola Medical AB (OSTO:NEOLA) has a FCF Yield % of -15.55 as of Jul. 07, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Neola Medical AB and its competitors. According to the industry distribution chart, Neola Medical AB ranks #682 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 79.7%.
Is Neola Medical AB's FCF Yield % too high?
Neola Medical AB's current FCF Yield % is -15.55. Based on the distribution chart, Neola Medical AB ranks #682 out of 856 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Neola Medical AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Neola Medical AB ranks #682 out of 856 companies for FCF Yield %. This places Neola Medical AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Neola Medical AB and its competitors. Neola Medical AB's current FCF Yield % is -15.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current FCF Yield % of -15.55. The current FCF Yield % is -15.55. Neola Medical AB's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current FCF Yield % is -15.55 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
29GF Score
Get the complete analysis for OSTO:NEOLA
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:NEOLA has been successfully added to your 
